课题基金 / 基金详情

Applying Biomarkers to Long-term Effects in Child and Adolescent Cancer Treatment (ABLE Team)

Applying Biomarkers to Long-term Effects in Child and Adolescent Cancer Treatment (ABLE Team)
将生物标志物应用于儿童和青少年癌症治疗的长期效果（ABLE 团队）
批准号：
234948
负责人：
Schultz Kirk R
金额：
$295.99万
依托单位：
BC Children's Hospital Research Institute
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2011
资助国家：
加拿大
项目状态：
已结题
起止时间：
2011-06-01 至 2016-06-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=234948&lang=en
关键词：
Biomarkers Chronic Graft Versus Host Disease Clinical Interventions Long Term Effects Of Cancer Therapy Nephrotoxicity Oto-Toxicity Thrombosis

项目摘要

项目成果

Schultz Kirk R的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Fortunately, through the application of modern medical practice, many children are now cured of cancer. Unfortunately many of these survivors experience unwanted side effects that lead to health issues throughout their lives. It would be very helpful if w
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulatory Natural Killer Cell Treatment in Chronic Graft-versus-Host Disease and Solid Organ Transplantation Chronic Rejection
  • 批准号：
    441672
  • 项目类别：
    Operating Grants
  • 资助金额：
    $54.64万
  • 财政年份：
    2021
  • 负责人：
    Schultz Kirk R
  • 依托单位：
    University of British Columbia
Correlative Studies to Improve Blood and Marrow Transplantation and Leukemia Immunotherapy in Children
CaPITTAL: Canadian Patient-oriented Immune Tolerance in Transplantation and Autoimmunity to improve Lives
  • 批准号：
    323878
  • 项目类别：
    Operating Grants
  • 资助金额：
    $3.64万
  • 财政年份：
    2015
  • 负责人：
    Schultz Kirk R
  • 依托单位：
    University of British Columbia
Applying Biomarkers to Long-term Effects in Child and Adolescent Cancer Treatment (ABLE Team)
海外基金